This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Amy Guillaumet-Adkins: Innovator in T-Cell Therapy
Introduction
Amy Guillaumet-Adkins is a prominent inventor based in Allston, MA (US). She has made significant contributions to the field of medical research, particularly in the area of T-cell therapy for leukemia. Her innovative work has the potential to impact the treatment of patients suffering from T-cell acute lymphoblastic leukemia.
Latest Patents
Amy holds a patent titled "Targeting Galectin-9 as a Therapeutic Strategy for T-Cell Exhaustion in T-Cell Acute Lymphoblastic Leukemia." This patent represents her groundbreaking approach to addressing T-cell exhaustion, which is a critical challenge in effective cancer treatment. She has 1 patent to her name, showcasing her commitment to advancing medical science.
Career Highlights
Amy is affiliated with The Brigham and Women's Hospital, Inc., where she conducts her research. Her work at this esteemed institution allows her to collaborate with leading experts in the field and contribute to innovative therapeutic strategies.
Collaborations
Amy has worked alongside notable colleagues such as Praveen Anand and Jon C. Aster. These collaborations enhance her research efforts and foster a dynamic environment for innovation in cancer therapy.
Conclusion
Amy Guillaumet-Adkins is a dedicated inventor whose work in T-cell therapy is paving the way for new treatment options in leukemia. Her contributions to medical research are invaluable and highlight the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile